BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4913152)

  • 1. A comparison of haloperidol and thioridazine HC1 in chronic treatment-resistant schizophrenics.
    Gonier T; Schiele BC; Vestre ND
    Behav Neuropsychiatry; 1970; 2(3):47-9 passim. PubMed ID: 4913152
    [No Abstract]   [Full Text] [Related]  

  • 2. Haloperidol and thioridazine in treatment of chronic schizophrenics.
    Prasad L; Townley MC
    Dis Nerv Syst; 1966 Nov; 27(11):722-6. PubMed ID: 5925664
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia.
    Weston MJ; Bentley R; Unwin A; Morris M; Harper MA
    Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics.
    Hall WB; Vestre ND; Schiele BC; Zimmermann R
    Dis Nerv Syst; 1968 Jun; 29(6):405-8. PubMed ID: 4877748
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Comparison of the effect of oxypertine and thioridazine on sensorimotor activity in chronic schizophrenics (a controlled study).
    Remr J; Nekolová J; Heinzl Z
    Act Nerv Super (Praha); 1975; 17(4):213-4. PubMed ID: 3930
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind comparison of haloperidol (Haldol) and thioridazine (Mellaril) in outpatient children.
    Claghorn JL
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):785-9. PubMed ID: 4629817
    [No Abstract]   [Full Text] [Related]  

  • 7. Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
    Martin IC
    Acta Psychiatr Scand; 1975 Feb; 51(2):110-8. PubMed ID: 235189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial.
    Borison RL; Sinha D; Haverstock S; McLarnon MC; Diamond BI
    Psychopharmacol Bull; 1989; 25(2):190-3. PubMed ID: 2574893
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of phenothiazine and nonphenothiazine neuroleptics according to psychopathology, side effects and computerized EEG.
    Itil TM; Patterson CD; Keskiner A; Holden JM
    Adv Biochem Psychopharmacol; 1974; 9(0):499-509. PubMed ID: 4599437
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of selected antipsychotic drugs of human judgment.
    Gillis JS
    Curr Ther Res Clin Exp; 1977 Feb; 21(2):224-32. PubMed ID: 403057
    [No Abstract]   [Full Text] [Related]  

  • 11. The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics.
    Kurland AA; Dim BH; Olsson JE
    Dis Nerv Syst; 1970 Sep; 31():Suppl:18-23. PubMed ID: 5476356
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum prolactin and clinical state during neuroleptic treatment and withdrawal.
    Laughren TP; Brown WA; Williams BW
    Am J Psychiatry; 1979 Jan; 136(1):108-10. PubMed ID: 758812
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrocardiographic evaluation of thiothixene: a double-blind comparison with thioridazine.
    Dillenkoffer RL; George RB; Bishop MP; Gallant DM
    Adv Biochem Psychopharmacol; 1974; 9(0):487-95. PubMed ID: 4599436
    [No Abstract]   [Full Text] [Related]  

  • 14. Haloperidol and thioridazine drug levels and clinical response in schizophrenia: comparison of gas-liquid chromatography and radioreceptor drug level assays.
    Smith RC; Baumgartner R; Burd A; Ravichandran GK; Mauldin M
    Psychopharmacol Bull; 1985; 21(1):52-8. PubMed ID: 3983338
    [No Abstract]   [Full Text] [Related]  

  • 15. CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients.
    Villeneuve C; Ananth JV; Ban TA; Lehmann HE
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):223-9. PubMed ID: 4985943
    [No Abstract]   [Full Text] [Related]  

  • 16. Double blind comparative study of the effects of thiothixene and thioridazine in twenty chronic schizophrenic patients.
    Hardeman WJ; Bakker SJ
    Psychiatr Neurol Neurochir; 1970; 73(1):1-7. PubMed ID: 4907371
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of thioridazine tablets to chlorpromazine spansules in the maintenance care of chronic schizophrenics.
    Bartlett C
    Curr Ther Res Clin Exp; 1971 Feb; 13(2):100-6. PubMed ID: 4994211
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind comparison of haloperidol and thioridazine in treatment resistant psychoneurotic outpatients.
    Lingl FA
    Psychosomatics; 1973; 14(4):235-40. PubMed ID: 4604344
    [No Abstract]   [Full Text] [Related]  

  • 19. Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study.
    Tsuang MM; Lu LM; Stotsky BA; Cole JO
    J Am Geriatr Soc; 1971 Jul; 19(7):593-600. PubMed ID: 4937658
    [No Abstract]   [Full Text] [Related]  

  • 20. Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.
    Gerlach J; Simmelsgaard H
    Psychopharmacology (Berl); 1978 Oct; 59(2):105-12. PubMed ID: 103110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.